DE MANZONI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 13.498
EU - Europa 12.431
AS - Asia 8.952
SA - Sud America 1.182
AF - Africa 360
Continente sconosciuto - Info sul continente non disponibili 351
OC - Oceania 35
AN - Antartide 1
Totale 36.810
Nazione #
US - Stati Uniti d'America 13.205
RU - Federazione Russa 4.715
SG - Singapore 3.689
GB - Regno Unito 2.785
CN - Cina 2.539
IT - Italia 1.345
BR - Brasile 948
HK - Hong Kong 784
VN - Vietnam 744
DE - Germania 653
SE - Svezia 648
FR - Francia 611
IE - Irlanda 583
FI - Finlandia 454
KR - Corea 314
UA - Ucraina 174
BD - Bangladesh 156
CA - Canada 140
TR - Turchia 128
JP - Giappone 115
IN - India 102
NL - Olanda 89
NG - Nigeria 81
ES - Italia 77
MX - Messico 77
AR - Argentina 75
IQ - Iraq 60
AT - Austria 55
ZA - Sudafrica 55
ID - Indonesia 54
TG - Togo 48
PL - Polonia 44
BE - Belgio 40
BJ - Benin 38
EC - Ecuador 38
AU - Australia 31
UZ - Uzbekistan 31
CO - Colombia 30
PK - Pakistan 29
PY - Paraguay 28
CZ - Repubblica Ceca 23
RW - Ruanda 22
EG - Egitto 21
JO - Giordania 21
LT - Lituania 21
IL - Israele 20
AE - Emirati Arabi Uniti 18
CL - Cile 18
SA - Arabia Saudita 18
VE - Venezuela 18
KE - Kenya 17
PH - Filippine 17
IR - Iran 16
MA - Marocco 15
KG - Kirghizistan 14
NO - Norvegia 14
DZ - Algeria 12
MY - Malesia 12
PT - Portogallo 12
UY - Uruguay 12
PA - Panama 11
TN - Tunisia 11
GR - Grecia 10
HN - Honduras 10
JM - Giamaica 10
PE - Perù 10
AL - Albania 9
EU - Europa 9
LV - Lettonia 9
CR - Costa Rica 8
AO - Angola 7
BG - Bulgaria 7
ET - Etiopia 7
KZ - Kazakistan 7
OM - Oman 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
AZ - Azerbaigian 6
CH - Svizzera 6
DO - Repubblica Dominicana 6
RO - Romania 6
BY - Bielorussia 5
LB - Libano 5
SN - Senegal 5
TH - Thailandia 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
BH - Bahrain 4
GE - Georgia 4
GT - Guatemala 4
HR - Croazia 4
HU - Ungheria 4
MK - Macedonia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
RS - Serbia 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
BB - Barbados 3
Totale 36.403
Città #
Southend 2.395
Singapore 1.955
Moscow 1.511
Ashburn 1.475
San Jose 1.301
Jacksonville 1.158
Chandler 1.142
Dallas 989
Hong Kong 776
Woodbridge 699
Verona 673
Dublin 578
Council Bluffs 544
Ann Arbor 460
Beijing 449
The Dalles 408
Houston 323
New York 311
Ho Chi Minh City 273
Los Angeles 245
Lawrence 204
Princeton 204
Wilmington 199
Jinan 182
Hanoi 164
Nanjing 157
Munich 141
Shenyang 140
Redmond 133
Milan 122
Buffalo 121
Helsinki 111
Tokyo 102
Hebei 100
Santa Clara 99
Sindelfingen 97
São Paulo 91
London 85
Redondo Beach 80
Abuja 78
Columbus 77
Tianjin 74
Changsha 69
Nanchang 62
Seoul 60
Zhengzhou 60
Guangzhou 56
Haikou 56
Amsterdam 52
Orem 52
Seattle 52
Atlanta 49
Jiaxing 48
Lomé 48
Ningbo 47
Frankfurt am Main 46
Chicago 44
Boardman 43
Rome 42
Brooklyn 41
Montreal 41
Stockholm 41
Brussels 40
Taizhou 39
Cotonou 38
Denver 38
Hangzhou 38
Warsaw 37
Phoenix 36
San Francisco 36
Turku 36
Vienna 34
Nuremberg 33
Johannesburg 32
Rio de Janeiro 31
Dearborn 30
Toronto 30
Madrid 29
Mexico City 28
Norwalk 28
Baghdad 27
Boston 26
Tashkent 26
Chennai 24
Haiphong 24
Manchester 24
Washington 24
Lappeenranta 23
Ankara 22
Belo Horizonte 22
Jakarta 22
Kigali 22
Paris 22
Taiyuan 22
Curitiba 21
Dong Ket 21
Fuzhou 21
Poplar 21
Redwood City 21
Amman 20
Totale 22.503
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 318
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 297
Segmental transverse colectomy. Minimally invasive versus open approach: results from a multicenter collaborative study 289
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 289
[Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction]. 268
Genomic characterization of hepatoid tumors: context matters 261
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 257
Pediatric Palliative Care: Historical Origins and a Glimpse into Ethical Issues 236
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 229
Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus study 224
Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years 220
[Advanced gastric adenocarcinoma with RER+ phenotype presents a good prognosis after 5 years of curative resection] 212
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 209
Adenocarcinoma of the esophagogastric junction 209
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. 208
Extension of lymphadenectomy for gastric cancer:Audit at European specialist centres. 207
Valutazione dell’applicabilità del modello organizzativo della weeksurgery alle Chirurgia Generale di un Presidio di un’AziendaOspedaliera del Veneto 205
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 204
ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer 202
Acute hemorrhage secondary to gastric ulcer. Results of emergency endoscopic treatment in 775 cases. 200
hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications. 200
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 200
The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours 198
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 198
Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker 196
Enhanced recovery protocol in esophagectomy, is it really worth it? A cost analysis related to team experience and protocol compliance 195
Emergency sclerotherapy in esophageal and gastric acutely variceal bleeding : ten years expérience (1988-1997). 195
Clinical pathways in gastric cancer care 194
Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients 191
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 190
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 189
Valutazione di uno screening colonscopico in pazienti ad alto rischio di CRC 186
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 184
Changing clinical and pathological features of gastric cancer over time. 183
Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. 182
Via biliare principale, pancreatite acuta e chirurgia mini-invasiva. 181
Textbook outcome following oesophagectomy for cancer: international cohort study 180
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 180
A new way to experience the International Gastric Cancer Association congress: the Web Round Tables 179
Lymphadenectomy for gastric cancer at European specialist centres 179
Short-term and long-term risk factors in gastric cancer 178
Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci 177
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 176
Microsatellite instability in gastric cancer is associated with better prognosis only in stage II cancers 175
Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction 175
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 174
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 171
[Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up] 170
Endoscopic submucosal dissection in the treatment of gastric submucosal tumors: results from a retrospective cohort study. 170
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy 170
Perianal Paget's disease: presentation of six cases and literature review. 169
Effectiveness of endoscopic vacuum therapy as rescue treatment in refractory leaks after gastro-esophageal surgery 169
Authors' reply: Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci (letter) 167
Experience on complex incisional hernia treatment in septic patients 167
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study 166
Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume Center. 165
Tumor Site and Perigastric Nodal Status are the Most Important Predictors of Para-Aortic Nodal Involvement in Advanced Gastric Cancer 163
[Patterns of transition between lymphangioma and intestinal lymphangiectasia. RAdiologic and histologic aspects of 2 cases with predominant involvement of the colon]. 163
Lack of an association between circulating adiponectin levels and risk of colorectal adenoma. 163
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study 163
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne 162
Factors influencing survival after hepatectomy for metastases from gastric cancer 162
Enhanced Recovery After Surgery can Improve Patient Outcomes and Reduce Hospital Cost of Gastrectomy for Cancer in the West: A Propensity-Score-Based Analysis 162
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 162
Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus 160
The value of in vitro ultrasonography in the intraoperative staging of gastric cancer. Blind study of 93 cases. 159
Using the Angio-Seal to Achieve Hemostasis in Prosthetic Endovascular Surgery: Report of Three Cases 159
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 158
Perigastric lymph node metastasis in gastric cancer: comparison between different staging systems 158
Complications after gastrectomy for cancer: Italian perspective 158
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer 158
Western strategy for EGJ carcinoma 155
Biomarkers of myocardial infarction in patients undergoing gastrointestinal cancer surgery 154
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience 153
Management of critically ill surgical patients Case reports 153
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 151
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 151
Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study 151
Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer 151
Induction chemio-radiotherapy for squamous cell carcinoma of the thoracic esophagus: long-term results of a phase 2 study 150
Surgical treatment of gastric cancer with coexistent abdominal aortic aneurysm. Personal experience and literature review 150
Iatrogenic axillary artery injury from humeral neck fracture repair. A rare and unusual event in which and aggressive strategy was mandatory to save a child limb 150
Proximal Gastrectomy: Technical Notes 150
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 150
Effect of Pyloroplasty on Gastric Conduit Emptying and Patients' Quality of Life After Ivor Lewis Esophagectomy 150
Lymphadenectomy: how to do it? 149
Preliminary Experience with Prophylactic Thoracic Endovascular Aortic Repair in Patients Affected by Advanced Esophageal Cancer 149
Lymphatic spread, lymph node stations, and levels of lymphatic dissection in gastric cancer 148
Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer 148
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 148
Endosonography in esophageal cancer staging after preoperative chemo and radiotherapy. 146
Strengths and Limitations of the Evidence-Based Movement Aimed to Improve Clinical Outcomes in Dentistry and Oral Surgery 146
Utility of Abdominal Drain in Gastrectomy (ADiGe) Trial: study protocol for a multicenter non-inferiority randomized trial 146
Evaluation of Siewert classification in gastro-esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography? 145
Lymph node involvement in advanced gastroesophageal junction adenocarcinoma 145
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 144
Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis 144
Induction chemo-radiotherapy for squamous cell carcinoma of the thoracic esofagus: impact of increased dosage on long-term results. 144
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 143
Early Gastric Cancer: Clinical Behavior and Treatment Options. Results of an Italian Multicenter Study on Behalf of the Italian Gastric Cancer Research Group (GIRCG) 143
Totale 17.980
Categoria #
all - tutte 130.637
article - articoli 117.438
book - libri 1.725
conference - conferenze 6.783
curatela - curatele 0
other - altro 688
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.003
Totale 261.274


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.427 0 382 37 129 83 39 40 111 53 53 121 379
2022/20233.544 242 310 327 622 297 867 14 255 384 27 88 111
2023/20242.015 58 167 170 254 219 321 108 110 25 121 351 111
2024/20255.515 295 333 273 846 267 183 400 291 747 453 417 1.010
2025/202615.612 1.093 746 971 2.510 3.896 1.121 1.574 897 1.242 885 302 375
2026/2027786 229 557 0 0 0 0 0 0 0 0 0 0
Totale 36.810